| payload |
{"created_at":"2026-04-22T14:18:39.834 {"created_at":"2026-04-22T14:18:39.834359+00:00","signal_type":"news_headline_delta","source":"news_rss","url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPMUV0bGlIT2FTbVZ0d1hQWnZPRFBBbGxjcTJPc1NIWjlzQmhZSnZfQnBJd2FSaDNQS0UxS2J2VXJhby1aRlozRlgtS2Q0UVNlT3BfekR2VjNmTzBqYTJFU0JISTZiYzBuMnRmak5mUzFfbkEzMWRaUFlFcUxMTnZGbXdxdVFqNzV5Y1VYSWprb2Q0TTVEVlZLNWxNU2ROUkkwb0w4eTM0aGlaU1NFRUlLU1BNbw?oc=5","value":{"fp":"f7f4316d5a84c67c","published_at":"2026-04-22T14:08:27+00:00","source":"Drug Discovery News","source_domain":"drugdiscoverynews.com","source_url":"https://www.drugdiscoverynews.com","summary":"Biogen expands control of CD38 antibody felzartamab across global markets Drug Discovery News","title":"Biogen expands control of CD38 antibody felzartamab across global markets - Drug Discovery News","url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPMUV0bGlIT2FTbVZ0d1hQWnZPRFBBbGxjcTJPc1NIWjlzQmhZSnZfQnBJd2FSaDNQS0UxS2J2VXJhby1aRlozRlgtS2Q0UVNlT3BfekR2VjNmTzBqYTJFU0JISTZiYzBuMnRmak5mUzFfbkEzMWRaUFlFcUxMTnZGbXdxdVFqNzV5Y1VYSWprb2Q0TTVEVlZLNWxNU2ROUkkwb0w4eTM0aGlaU1NFRUlLU1BNbw?oc=5"}}... |